Observatoire des droits humains (anglais seulement)

The weight loss drug Mounjaro has been approved to treat sleep apnoea. How does it work?

(Version anglaise seulement)

par Yaqoot Fatima, Professor of Sleep Health, University of the Sunshine Coast
Nisreen Aouira, Research Program Manager, Thompson Institute, University of the Sunshine Coast

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which breathing stops and starts repeatedly during sleep.

The TGA has indicated Mounjaro can be used to treat moderate to severe obstructive sleep apnoea…

Lire l'article complet